H-1B sponsorship profile: Fibrogen, Inc. Across U.S. Department of Labor LCA disclosures, Fibrogen, Inc filed 27 Labor Condition Applications covering 27 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 96.3% (26 certified of 27 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Fibrogen, Inc’s H-1B petitions range from $86,195 at the low end to $227,635 at the high end, with a petition-weighted average of $146,240. That range reflects the mix of occupations the company sponsors, led by Clinical Trial Manager (4 petitions at $156,151 avg), followed by Sr. Director, Forecasting & Analytics and Senior Manager, Clinical Programming. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Fibrogen, Inc is headquartered in San Francisco, CA under NAICS code 32541, and places H-1B workers across 5 states, most heavily in CA, TX, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Fibrogen, Inc ranks. By H-1B petition volume, Fibrogen, Inc is #8,004 of 119,880 employers nationally and #1,170 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.